These results are reminiscent of those observed in the 3 PM-COX subjects with clinical features of IBM, again consistent with the notion that LC3 immunopositivity represents an early and TDP-43 immunopositivity a late marker of IBM. Here, TARDBP is linked to inclusion body myositis.